Johnson & JohnsonJNJ

Is JNJ cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$271.04+2.31 (+0.86%)24:00 UTC

NYSEHealthcareDividend King

Company snapshot

Market Cap

$664B

Mega-cap

+96%

2016 — today

10-Year Price

+123%

2016 — today

52-Week Range

$186.00$278.43

Current $271.04· 92%

Johnson & Johnson (JNJ) researches, develops, and distributes healthcare products globally. Following the 2023 divestiture of its Consumer Health division (Kenvue), the company now focuses on two core segments: Innovative Medicine and MedTech. Innovative Medicine produces prescription drugs for complex conditions like cancer, HIV/AIDS, and neurodegenerative disorders. MedTech delivers surgical technologies, orthopaedic implants, and ACUVUE contact lenses. J&J has advanced human health since 1886.

Featured in rankings

Dividend Kings S&P500 Dow Jones Dividend Aristocrats Most Undervalued Healthcare Stocks Best Healthcare Dividend Stocks Most Undervalued Value Stocks Most Undervalued Dividend Stocks Most Undervalued Growth Stocks Cheapest Large-Cap Stocks

Rankings recomputed after each US market close — see where JNJ stands against peers.

Similar companies

Healthcare companies of comparable size to JNJ
Company	P/E	Div yield
ABBVAbbVie Inc.	80.6	2.4%
LLYEli Lilly and Company	43.2	0.5%
UNHUnitedHealth Group Incorporated	23.2	2.2%
MRKMerck & Co., Inc.	112.7	2.4%
NVSNovartis AG	23.5	3.0%
AZNAstraZeneca PLC	25.5	1.9%
TMOThermo Fisher Scientific Inc.	37.1	0.3%
AMGNAmgen Inc.	28.1	2.2%